0,881  0,008  Apoptosis agonist
0,863  0,004  Prostate cancer treatment
0,837  0,004  Cardiovascular analeptic
0,824  0,012  Antiinflammatory
0,804  0,009  Antineoplastic (breast cancer)
0,769  0,008  Antileukemic
0,756  0,017  Caspase 9 stimulant
0,595  0,015  Sensitization
0,594  0,026  TNF expression inhibitor
0,581  0,013  Antineoplastic (pancreatic cancer)
0,581  0,033  Antineoplastic (lung cancer)
0,535  0,007  Antineoplastic (sarcoma)
0,540  0,013  Nitric oxide antagonist
0,523  0,032  Antineoplastic (colorectal cancer)
0,505  0,021  Antifungal
0,513  0,032  Antineoplastic (colon cancer)
0,486  0,020  NOS2 expression inhibitor
0,493  0,028  Antineoplastic (ovarian cancer)
0,507  0,043  Transcription factor NF kappa B inhibitor
0,478  0,024  AR expression inhibitor
0,461  0,009  Growth hormone agonist
0,457  0,008  Contraceptive
0,452  0,009  Abortion inducer
0,448  0,005  Antineoplastic antibiotic
0,451  0,015  Antineoplastic (endocrine cancer)
0,442  0,020  Antineoplastic (lymphoma)
0,465  0,044  Antipruritic, allergic
0,446  0,028  NOS3 expression inhibitor
0,426  0,025  UGT2B4 substrate
0,429  0,044  Cholesterol antagonist
0,394  0,011  Antipruritic, non-allergic
0,400  0,017  Sodium/bile acid cotransporter inhibitor
0,417  0,034  ICAM1 expression inhibitor
0,423  0,040  Respiratory analeptic
0,388  0,010  Lipocortins synthesis antagonist
0,387  0,017  Antiparkinsonian, rigidity relieving
0,390  0,025  Antineoplastic (liver cancer)
0,394  0,030  Cardiotonic
0,391  0,028  Calcium channel activator
0,375  0,013  Prostate disorders treatment
0,407  0,044  5 Hydroxytryptamine release stimulant
0,397  0,040  Antineoplastic (brain cancer)
0,389  0,037  Antioxidant
0,388  0,038  Antineoplastic (glioma)
0,368  0,019  UGT1A4 substrate
0,376  0,031  Antihypoxic
0,372  0,031  Chemopreventive
0,356  0,017  UGT2B7 substrate
0,353  0,014  Interferon gamma antagonist
0,356  0,017  Antiviral (Influenza)
0,398  0,064  CYP2C9 substrate
0,354  0,022  UGT1A1 substrate
0,373  0,047  Antineoplastic (melanoma)
0,370  0,045  Analeptic
0,329  0,008  UGT2B9 substrate
0,351  0,032  Transcription factor STAT3 inhibitor
0,332  0,018  Prostatic (benign) hyperplasia treatment
0,390  0,081  Antibacterial
0,352  0,046  UGT1A9 substrate
0,323  0,018  Antineoplastic (squamous cell carcinoma)
0,308  0,016  UGT2B15 substrate
0,304  0,017  Neurotrophic factor enhancer
0,318  0,031  UDP-glucuronosyltransferase substrate
0,328  0,042  Transcription factor STAT inhibitor
0,301  0,016  Antiviral (Influenza A)
0,340  0,055  Cardioprotectant
0,287  0,003  Adenylate cyclase stimulant
0,356  0,076  CYP3A4 substrate
0,299  0,022  Antiacne
0,319  0,045  Antineoplastic (renal cancer)
0,321  0,048  Cytotoxic
0,286  0,013  Cholesterol synthesis inhibitor
0,314  0,041  UGT1A6 substrate
0,284  0,015  Adenylate cyclase inhibitor
0,307  0,041  5 Hydroxytryptamine uptake stimulant
0,325  0,060  Aldehyde oxidase inhibitor
0,309  0,050  Proliferative diseases treatment
0,313  0,054  Antineoplastic (cervical cancer)
0,289  0,034  Antihelmintic
0,287  0,034  Hepatoprotectant
0,295  0,044  Antiparasitic
0,310  0,059  Antineoplastic (multiple myeloma)
0,308  0,063  CYP2C19 substrate
0,255  0,012  UGT2B10 substrate
0,314  0,072  Caspase 3 stimulant
0,258  0,016  Antifungal enhancer
0,259  0,018  Toxic, respiratory center
0,250  0,008  Contraceptive female
0,247  0,008  Antirickettsial
0,313  0,075  Hepatic disorders treatment
0,286  0,051  Antineoplastic (glioblastoma multiforme)
0,242  0,009  Contraceptive male
0,239  0,008  Arachidonic acid antagonist
0,286  0,058  GST M1-1 substrate
0,277  0,051  Gastrin inhibitor
0,244  0,018  Psychosexual dysfunction treatment
0,230  0,007  Transcription factor NF kappa B stimulant
0,294  0,075  CTGF expression inhibitor
0,231  0,014  Farnesoid X receptor antagonist
0,308  0,093  Vasodilator, peripheral
0,268  0,064  Heart failure treatment
0,251  0,050  Anesthetic general
0,208  0,008  Estrogen agonist
0,250  0,049  RNA-directed DNA polymerase inhibitor
0,235  0,035  UGT1A3 substrate
0,233  0,037  Acaricide
0,208  0,013  Antispirochetal
0,303  0,109  GST A substrate
0,203  0,010  Pregnane X receptor agonist
0,262  0,073  Antihypercholesterolemic
0,244  0,058  Antiviral (HIV)
0,203  0,019  Microtubule formation inhibitor
0,259  0,077  Chemoprotective
0,274  0,093  Antineoplastic (osteosarcoma)
0,215  0,035  Acute respiratory distress syndrome (ARDS) treatment
0,235  0,056  Antialcoholic
0,265  0,087  Hypoxia-inducible factor 1 alpha inhibitor
0,279  0,102  FMO1 substrate
0,183  0,006  UGT2B11 substrate
0,212  0,037  Anesthetic
0,189  0,015  Androgen antagonist
0,194  0,020  SULT1A1 substrate
0,220  0,047  Antimutagenic
0,176  0,005  Estrogen receptor alpha agonist
0,177  0,008  Anabolic
0,206  0,039  Protein kinase stimulant
0,239  0,073  Cardiodepressant
0,264  0,099  CYP2D6 substrate
0,253  0,089  Antituberculosic
0,171  0,008  Paget's disease treatment
0,236  0,075  Free radical scavenger
0,172  0,011  Ca2+-transporting ATPase inhibitor
0,203  0,043  Antineoplastic (carcinoma)
0,182  0,022  Anticataract
0,160  0,002  Heme oxygenase stimulant
0,234  0,078  DNA synthesis inhibitor
0,194  0,038  Antidiarrheal
0,169  0,015  Actinic keratosis treatment
0,179  0,025  Endometrios treatment
0,197  0,044  Antiparkinsonian, tremor relieving
0,158  0,005  Na+ K+ transporting ATPase inhibitor
0,158  0,006  Glycine receptor agonist
0,196  0,046  Hair growth stimulant
0,156  0,006  Glycine receptor antagonist
0,193  0,044  Melanin inhibitor
0,170  0,022  Antineoplastic alkaloid
0,194  0,049  Antiviral (Herpes)
0,168  0,025  Choleretic
0,309  0,168  Autoimmune disorders treatment
0,163  0,023  TRPA1 agonist
0,150  0,011  Lanosterol 14 alpha demethylase inhibitor
0,151  0,013  CDC25A inhibitor
0,250  0,113  Bone diseases treatment
0,176  0,040  CF transmembrane conductance regulator agonist
0,170  0,035  Retinoprotector
0,142  0,008  Estrogen receptor beta agonist
0,148  0,016  SULT1E1 substrate
0,183  0,052  Diuretic
0,136  0,008  Narcotic antagonist
0,242  0,115  Antimycobacterial
0,184  0,057  Phospholipase C inhibitor
0,213  0,088  Angiogenesis stimulant
0,152  0,028  UGT2B1 substrate
0,163  0,041  Protein-tyrosine phosphatase 1B inhibitor
0,124  0,003  Adenylate cyclase 1 inhibitor
0,128  0,006  Aldosterone antagonist
0,191  0,070  P-glycoprotein inhibitor
0,166  0,046  Alpha-N-acetylglucosaminidase inhibitor
0,127  0,008  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,313  0,195  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,196  0,078  Pneumotoxic
0,148  0,031  GABA C receptor antagonist
0,161  0,045  Antifungal (Cryptococcus)
0,141  0,028  Estrogen antagonist
0,123  0,010  Anticholelithogenic
0,136  0,024  Antiviral (SARS coronavirus)
0,136  0,024  Antiviral (Coronavirus)
0,116  0,004  Postcoital contraceptive
0,157  0,046  DNA polymerase I inhibitor
0,115  0,005  SULT2A1 substrate
0,140  0,031  Antiinfertility, female
0,123  0,014  Postmenopausal disorders treatment
0,181  0,073  LDLR expression enhancer
0,144  0,037  Alcohol dehydrogenase substrate
0,111  0,005  Anesthetic inhalation
0,123  0,017  Bile acid receptor antagonist
0,200  0,094  Teratogen
0,122  0,021  Glutamate release inhibitor
0,165  0,066  Protein-tyrosine phosphatase inhibitor
0,122  0,023  Opioid kappa receptor antagonist
0,139  0,041  CC chemokine 6 receptor antagonist
0,147  0,051  Antihyperlipoproteinemic
0,142  0,047  Growth stimulant
0,127  0,033  GST T1-1 substrate
0,123  0,029  ABCA1 expression enhancer
0,200  0,107  Antipyretic
0,234  0,143  Apoptosis antagonist
0,105  0,013  Androgen agonist
0,098  0,006  RNA-directed RNA polymerase stimulant
0,114  0,024  Keratolytic
0,191  0,101  Cyclic AMP phosphodiesterase inhibitor
0,187  0,097  Embryotoxic
0,182  0,092  Insulin sensitizer
0,199  0,109  Antihypotensive
0,193  0,104  Antineoplastic (lymphocytic leukemia)
0,120  0,032  Estrogen receptor beta antagonist
0,116  0,029  Ornithine decarboxylase inhibitor
0,142  0,055  Cyclooxygenase 3 inhibitor
0,180  0,093  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,130  0,043  GABA C receptor agonist
0,151  0,064  SULT1A3 substrate
0,171  0,085  Carcinogenic
0,160  0,075  Interleukin 6 antagonist
0,098  0,013  Antimycoplasmal
0,208  0,122  Tyrosine 3 hydroxylase inhibitor
0,122  0,037  Prolactin inhibitor
0,115  0,031  Antidote, mercury
0,136  0,056  Vanilloid 1 agonist
0,091  0,012  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,235  0,157  Ulceration
0,157  0,079  Antihelmintic (Nematodes)
0,081  0,005  GABA uptake inhibitor
0,198  0,122  Immunostimulant
0,085  0,011  Lipocortins synthesis agonist
0,176  0,102  VEGF expression inhibitor
0,216  0,142  FMO3 substrate
0,163  0,090  Antineoplastic (bone cancer)
0,163  0,091  Succinate dehydrogenase inhibitor
0,076  0,005  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,101  0,032  3C-Like protease (SARS coronavirus) inhibitor
0,080  0,011  Acetyl-CoA transferase 2 inhibitor
0,074  0,005  Parathyroid hormone antagonist
0,103  0,035  Tocolytic
0,073  0,006  Farnesoid X receptor agonist
0,096  0,030  Estrogen receptor alpha antagonist
0,075  0,010  Pregnane X receptor antagonist
0,133  0,068  Skin whitener
0,183  0,119  Antineoplastic (non-small cell lung cancer)
0,208  0,144  CYP1A2 substrate
0,158  0,098  Phobic disorders treatment
0,094  0,034  Estrogen-related receptor beta agonist
0,073  0,014  Opioid kappa receptor agonist
0,180  0,122  Cytostatic
0,065  0,010  Geranyltranstransferase inhibitor
0,189  0,135  Antiosteoporotic
0,064  0,010  Microtubule stabilization
0,107  0,055  Sulfotransferase substrate
0,215  0,165  Interleukin 2 agonist
0,184  0,135  Interleukin agonist
0,058  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,086  0,037  SULT1A2 substrate
0,054  0,007  Estrone sulfatase inhibitor
0,102  0,055  Antineoplastic, alkylator
0,059  0,013  Liver X receptor alpha agonist
0,124  0,078  Antihemorrhagic
0,208  0,162  CYP3A4 inhibitor
0,107  0,062  Glutathione S-transferase substrate
0,058  0,015  Progesterone antagonist
0,087  0,043  Ca(v)3.1 blocker
0,050  0,008  Tubulin agonist
0,060  0,021  Potassium channel Kv1.3 blocker
0,112  0,073  Menstruation disorders treatment
0,055  0,017  5-Alpha-reductase inhibitor
0,134  0,096  Mutagenic
0,082  0,045  Antibiotic
0,049  0,012  Glucose-6-phosphate dehydrogenase inhibitor
0,062  0,025  Alpha-mannosidase inhibitor
0,070  0,034  Hypercalcemia treatment
0,050  0,015  Glucocorticoid antagonist
0,040  0,004  Hedgehog signaling activator
0,072  0,037  Hyperparathyroidism treatment
0,145  0,110  ATPase inhibitor
0,081  0,047  Antidote, organophosphates
0,131  0,098  Eye irritation, high
0,071  0,038  Glutamate (mGluR6) antagonist
0,173  0,141  DNA damaging
0,206  0,176  Vasodilator, coronary
0,099  0,070  Expectorant
0,213  0,184  Immunosuppressant
0,032  0,003  Telomerase stimulant
0,126  0,098  Skeletal muscle relaxant
0,076  0,049  Vanilloid 4 agonist
0,044  0,018  Cholesterol absorption inhibitor
0,112  0,087  Coagulant
0,043  0,018  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,039  0,014  ATP citrate lysase inhibitor
0,128  0,104  Sphingosine 1-phosphate receptor 5 antagonist
0,063  0,039  Aromatase inhibitor
0,173  0,150  Radioprotector
0,051  0,028  Cholesterol esterase inhibitor
0,066  0,044  Uterine relaxant
0,029  0,009  GRP78 expression inhibitor
0,031  0,010  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,084  0,064  Opioid antagonist
0,068  0,049  Phosphofructokinase-1 inhibitor
0,049  0,031  Glucose-6-phosphate isomerase inhibitor
0,045  0,027  Estradiol 17 beta-dehydrogenase inhibitor
0,131  0,113  Uterine stimulant
0,027  0,009  Vitamin D receptor antagonist
0,025  0,008  Progesterone agonist
0,026  0,009  Corticosteroid-like
0,039  0,023  Retinoid X receptor agonist
0,034  0,018  Cholesterol ester transfer protein antagonist
0,021  0,006  Vitamin D receptor agonist
0,026  0,011  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,042  0,028  Hypogonadism treatment
0,018  0,005  Antibiotic Tetracycline-like
0,074  0,061  Acetylcholine nicotinic antagonist
0,043  0,031  Liver X receptor agonist
0,113  0,101  Lipid peroxidase inhibitor
0,039  0,027  Membrane dipeptidase inhibitor
0,111  0,099  Cocaine dependence treatment
0,057  0,046  Carbamoyl phosphate synthetase inhibitor
0,131  0,121  Movement disorders treatment
0,040  0,030  Kainate receptor agonist
0,160  0,150  VCAM1 expression inhibitor
0,021  0,012  Retinoid X beta receptor antagonist
0,178  0,170  Flavin-containing monooxygenase substrate
0,023  0,015  Retinoid X gamma receptor agonist
0,124  0,116  Muscle relaxant
0,087  0,079  Antithrombocytopenic
0,033  0,025  Antihyperaldosteronism
0,092  0,085  Toll-Like receptor 4 antagonist
0,033  0,026  Retinoid X alpha receptor agonist
0,013  0,006  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,100  0,093  Autism spectrum disorders treatment
0,026  0,020  Retinoid X gamma receptor antagonist
0,107  0,101  Antifungal (Pneumocystis)
0,016  0,010  NMDA receptor phencyclidine site antagonist
0,067  0,061  Glutamate dehydrogenase inhibitor
0,036  0,030  Retinoid X receptor antagonist
0,027  0,022  Liver X receptor beta antagonist
0,022  0,017  Retinoic acid gamma receptor agonist
0,041  0,038  Mannosidase inhibitor
0,032  0,029  Retinoid X alpha receptor antagonist
0,027  0,024  Liver X receptor alpha antagonist
0,006  0,004  Transcortin receptor antagonist
0,031  0,029  Carboxypeptidase B inhibitor
0,058  0,058  Interferon inducer
0,067  0,066  Nicotinic alpha4beta2 receptor antagonist
0,117  0,116  Genotoxic

